Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Tag: EAN

Clinical Catch-Up: January 10-14

Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting

via: Roche presented results from several Phase II and III trials at the 7th Congress of the European Academy of Neurology (EAN) Annual Meeting held virtually June 19-22. Some of the results specifically underscored the efficacy and safety of EVRYSDI™ (risdiplam) for motor neuron disease, Enspryng® (satralizumab)

Read More »